Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research Grade Cusatuzumab | Login | Research Grade Cusatuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Vorsetuzumab | Login | Research Grade Vorsetuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Pabinafusp Alfa | Login | Research Grade Pabinafusp Alfa | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Oleclumab | Login | Research Grade Oleclumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Milatuzumab | Login | Research Grade Milatuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Iladatuzumab | Login | Research Grade Iladatuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Avdoralimab | Login | Research Grade Avdoralimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Pepinemab | Login | Research Grade Pepinemab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Carotuximab | Login | Research Grade Carotuximab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Cabiralizumab | Login | Research Grade Cabiralizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Emactuzumab | Login | Research Grade Emactuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Axatilimab | Login | Research Grade Axatilimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Talacotuzumab | Login | Research Grade Talacotuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Vibecotamab | Login | Research Grade Vibecotamab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Flotetuzumab | Login | Research Grade Flotetuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Levilimab | Login | Research Grade Levilimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Vobarilizumab | Login | Research Grade Vobarilizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Ivuxolimab | Login | Research Grade Ivuxolimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Pogalizumab | Login | Research Grade Pogalizumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tavolimab | Login | Research Grade Tavolimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Cudarolimab | Login | Research Grade Cudarolimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Revdofilimab | Login | Research Grade Revdofilimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Telazorlimab | Login | Research Grade Telazorlimab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Narnatumab | Login | Research Grade Narnatumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Indatuximab | Login | Research Grade Indatuximab | ||||||||||||||||
|
||||||||||||||||||


